Member Info for passiton

agree analyst notes the other side of the pond for ten and twenty bucks prior to the acquisition viral combo drug
and now the Breast cancer ASCO News that $20 is """ £3.24p """"

so a revised note must be in the offing for way above twenty bucks as many on here and twits have stated this
could rapidly move to many multiples and as Mr Akers has joined the party who knows what he is expecting
most of his investments 10-25 bag so £3 .2 from here seems a bit low ball at 4 bags for him
Hope his usual standards are maintained we'll all be minted GLA

plan was for both Nas and AIm to be binned this quarter and replaced by straight non ads Nasdaq
listing, its only been postponed not cancelled (RNA) the raises and extra funding on the Nasdaq
and the volume when happened on the Nasdaq 3 days with 60M shares traded equivalent and aim
a lowly 14 so think the tail is wagging the dog the past few weeks, London has tried many times
blasting over 60p and beyond and falling back while the Nasdaq was solidly in the 47p - 56p range
followed nothing.
This past 3 sessions that has changed they are now moving, so expecting them to finally follow US
this time around, AIM still currently the primary listing even if money and volume has been on the
other side of the pond for weeks

Divide by 5 and multiply by 0.81

0.81 pence to the dollar rate for most of past few weeks

so 81p is $5 magic mark to look for on the Nasdaq to join us

you read my mind posted and your answer already up JA

If I remember from the weekend frenzy the embargoed presentation release was quoted as 2200 10pm
don't remember if that was EST or UK time anyone?

Yes know that but the twitter frenzy made ref to it all the other day as you say same source
who was reputed to have let leak (unconfirmed) the basis of the ASCO presentation to be
made and the huge fact ours rated better than the market leader

which as stated earlier was only recently taken out for multi billions

before all the latest news combo drug etc the Nasdaq analysts had targets of $10 and $20 which are
£1.62 and £3.24p surely those targets with covid developments and now ASCO added must be in
line for a revision UPWARDS

over 100 trades Nasdaq pre market although still a bit behind London price wise
normally zero to a few pre market trades
TODAY could be the day

That's what started the frenzy the other day, when a poster announced the Embargo on the presentation
for the ASCO which was reputed to say (no confirmation) ours is better than the leading product, which
was taken out recently by big Pharm for a good wedge over a billion dollars, if so we are a take over target
and have the other assets drugs etc to throw in the mix or keep, could be cashed up for years and still have
the other /covid projects, if not taken out completely.

the patent is for a specific coded humanised mouse, if you google you will find others that already supply
such H/mice for various uses to the markets, we do not have a monopoly on all modified mice just the super
human one's we have developed and others that will be developed and patented for other diseases in the
future.

would expect them to, it does say in the previous 21st April RNA today is the day and not being aim
if a date is mentioned in an RNA a follow up HAS to be issued on that date or asap if transaction
completed or not

(rule book one often let slide on aim but not on asx , tsx or the main markets normally)

Nasdaq has not and didn't for the past 6 weeks, the past few days its got closer to London so looking good to
finally make it a party

London has broken over 60p many times, Nasdaq only finally broke that 2 days ago

Nasdaq has crept up the past few sessions BUT still never got close to London price
needs to blast over $5 to catch current price

on the upside pre market trades again today with a high of $4.60 74.5p so looks like
the upward trend will continue today just need it to lose the concrete boots and
BREAKOUT

Latest RNA's shares in issue 17.9M , fundraise 18M shares so around 36m once the dust settles
at 25p would still only have a market capital of £9m exactly where several recent Pharm stocks
have started their rises on further news, most recently hemo sub/2p £9M MC to hit 15p recently
see no reason why VAL cannot form the same 25p/£9m base camp pending developments. GLA

this is Main Market and NOT a covid stock , it has entered the arena but already had stem cell studies
an effective treatment for CANCER aal/aml and a large pipeline of blood and virology projects with
Global Pharm's in collaborations was here before covid19 and will be here long after, how many of
the covid stocks can say the same

14P + 28P + 33P = 75P my target was a quid long term minimum so 75p will have to do lol

Porkies is his middle name, who remembers the podcast late 2019 where he said both
RHA in operation and EPO January sorted bosch, well here we are in May RHA yet to go
into production and the EPO still at the printers.
You have to admire the stones, to sit their year after year stringing it all along
at least after all these years the good news for shareholders is it's all now VERY IMMINENT

it was always a long term hold, MAIN MARKET pharm with multiple Global Pharm collaborations
including an already successful AAL/AML cancer treatment, the covid announcement brought
it to the attention of the market dominated covid is it crowd but Hemo will still be in vouge
when the rest slide away due to vaccines , viral treatments etc, the test kits will fade into the ether
as will only require limited stocks in case, hemo will have a treatment and developing a shield
for the next nasty that turns up sars 2009 covid 2019 the gap could be much larger or smaller
but it will come and the disease X project will hopefully prevent the same world shut down as
has occurred this time and more importantly a quick route to antibody treatments that will
prevent such high death rates.

phama's are never cheap during development and our super mice will cost a few quid a squeak

yes but was hoping with all the recent churn in the 9-11p range it was forward selling for a placing
at 8-8.5 been way too much volume to just be what has shown up on the TR-1's

Funded , projects progressing, onwards and upwards hopefully.